|
|
Article: Curis Provides Update on Hedgehog Agonist Hair Growth Program.
- Article from:
- Business Wire
- Article date:
- May 9, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, Mass. -- Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing novel targeted medicines primarily for cancer treatment, today provided an update on its topically applied Hedgehog agonist program for hair growth. Preclinical research efforts on Hedgehog agonist compounds for hair growth applications have been ongoing since September 2005 in collaboration with Procter & Gamble Pharmaceuticals, a division of The Procter & Gamble Company. Procter & Gamble has notified Curis that it has decided to terminate the collaboration agreement with Curis because the Hedgehog agonist compounds under development pursuant to the collaboration did not ...
Related newspaper, magazine, and journal articles:
|
|
Article: Study findings suggest strategy for regeneration of tissues in ...
Genomics & Genetics Weekly;
October 10, 2003 ;
700+ words
... ... the development of new drug candidates for neurological disorders. Recently, we have seen that Curis' Hedgehog agonist drug development candidates have shown efficacy in models of Parkinson's disease, diabetic neuropathy, and stroke ...
|
|